A study in Nature reveals a link between colibactin, a toxin produced by E. coli bacteria, and early-onset colorectal cancer. Researchers found colibactin-related mutations were three times more common in early-onset cancers compared to late-onset cases, suggesting the toxin plays a significant role in the disease's development. The increasing incidence of early-onset colorectal cancer in young adults might be partly explained by this finding. Further research is needed to confirm causality and explore potential interventions, including probiotics and early detection tests. Funding limitations threaten future progress in this vital area of cancer research.

Prepared by Olivia Bennett and reviewed by editorial team.